Common use of Sponsor Drug Clause in Contracts

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. 4.1.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) Drug to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. 4.1.

Sponsor Drug. Sponsor or its designee will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor or its designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. 4.1The Sponsor Drug (and, if applicable, the comparator drug) will be delivered to the hospital pharmacy of the Institution. 4.

Sponsor Drug. Sponsor or their designee will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor or their designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator). 4.15.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. 4.14.

Sponsor Drug. Sponsor or its designee will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor or its designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution. 4.14.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigatorplatnosti smlouvy smlouvu ukončit. 4.12.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. 4.1Sponsor will ensure the issuing of approvals from State Institute of Drug Control and etics committees. 4.

Sponsor Drug. Sponsor will provide Institution Provider with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution Provider and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution Provider and Principal Investigator. 4.1.

Sponsor Drug. Sponsor will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution. 4.1.

Sponsor Drug. Sponsor will provide Institution Healthcare Provider with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to ). For the Institution and Principal Investigatoravoidance of doubt Sponsor will not provide any Sponsor Drug following completion of the Trial. 4.15.1.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to ). For the Institution and Principal Investigatoravoidance of doubt Sponsor will not provide any Sponsor Drug following completion of the Trial. 4.1.5.1

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”). The Sponsor Drug (and, if applicable, the comparator drug) at no cost will be delivered to the Institution and Principal Investigatorhospital pharmacy of the Institution. 4.14.

Sponsor Drug. Sponsor will provide Institution to the Institution’s Pharmacy with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator). 4.15.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator). 4.15.